Key Drivers
- High ROE
- Solid Cash Flow
- Rich Valuation
AIAI Summary
GRDN looks more like a capital-efficient, acquisition-driven healthcare operator than a pure growth story, but with valuation already pricing in success, the key issue is whether improving margins and resident growth can overcome fragile quarterly cash conversion and integration risk.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High ROE
- •Solid Cash Flow
- •Rich Valuation
GRDN delivers strong capital returns and solid full-year cash flow with manageable leverage, but its expensive valuation and weak recent-quarter cash conversion temper the investment case.
Price Behavior
Key Price Behavior Insights:
- •Rebound strength
- •Key support hold
- •Resistance ceiling
Over the last month, GRDN has rebounded to the top of its range, but it still needs to hold above $40.5 and break $43.4 to confirm further upside.
Sharp late-June drop into the high-$38s followed by a quick rebound above $42
Sentiment & News
Key News Insights:
- •New-high momentum
- •Leadership transition
- •Virginia expansion
GRDN is showing strong stock momentum as it hits new highs and surges on volume, while leadership changes and a Virginia acquisition point to continued operational expansion despite some earnings pressure.
The news is modestly positive overall, supporting investor interest through growth initiatives and share strength, though near-term upside may be limited by valuation and earnings revision concerns
Similar Companies in Healthcare
Other companies in the same sector with AI ratings